Download PDF
1 / Pages

Other users also viewed these articles

Including KDIGO cardiovascular risk stratification into SCORE scale could improve the accuracy to better stratify cardiovascular risk Ana Cebrian; Carlos Escobar; Unai Aranda; Beatriz Palacios; Margarita Capel; Antoni Sicras; Aram Sicras; Antonio Hormigo; Nicolás Manito; Manuel Botana; Roberto Alcázar;
Nefrologia (English Version). 2024;44:292-4
Information and consensus document for the detection and management of chronic kidney disease Rafael García-Maset; Jordi Bover; Julián Segura de la Morena; Marian Goicoechea Diezhandino; Jesús Cebollada del Hoyo; Javier Escalada San Martin; Lorenzo Fácila Rubio; Javier Gamarra Ortiz; Jose A. García-Donaire; Lisardo García-Matarín; Sílvia Gràcia Garcia; María Isabel Gutiérrez Pérez; Julio Hernández Moreno; Pilar Mazón Ramos; Rosario Montañés Bermudez; Manuel Muñoz Torres; Pedro de Pablos-Velasco; Manuel Pérez-Maraver; Carmen Suárez Fernández; Salvador Tranche Iparraguirre; José Luis Górriz;
Nefrologia (English Version). 2022;42:233-64
Evaluation of clinical events and costs associated with the addition of dapagliflozin to chronic kidney disease treatment: Cost offset analysis Juan Francisco Navarro-González; Alberto Ortiz; Ana Cebrián Cuenca; Lluís Segú; Belén Pimentel; Unai Aranda; Blanca Lopez-Chicheri; Margarita Capel; Elisenda Pomares Mallol; Christian Caudron; Juan José García Sánchez; Roberto Alcázar Arroyo;
Nefrologia (English Version). 2024;44:857-67